Metabolomics analysis reveals characteristic metabolites in different levels of oxaliplatin‐induced neurotoxicity
Journal of Separation Science · 2024
DOI: 10.1002/jssc.202400164 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Separation Science, 2024. Verfasst von Yujiao Hua und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Affiliated Hospital of Jiangnan University, Wuxi, China. Hauptthemen laut MEDLINE: Oxaliplatin, Metabolomics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Lean Medication and Stone Medicine Special Research Fund Supported Project, Wuxi Municipal Health Commission Youth Project.
Abstract (Originalsprache)
Oxaliplatin (L‐OHP), a third‐generation platinum‐based anti‐tumor drug, finds widespread application in the first‐line treatment of metastatic colorectal cancer. Despite its efficacy, the drug's usage is curtailed by a litany of side effects, with L‐OHP‐induced peripheral neuropathy (OIPN) being the most debilitating. This condition can be classified into varying degrees of severity. Employing serum metabolomics, a high‐sensitivity, high‐throughput technique, holds promise as a method to identify biomarkers for clinical assessment and monitoring of OIPN patients across different severity levels. In our study, we analyzed serum metabolites in patients with different OIPN levels using ultra‐performance liquid chromatography‐high resolution mass spectrometry. By employing statistical analyses and pathway enrichment studies, we aimed to identify potential biomarkers and metabolic pathways. Our findings characterized the serum metabolic profiles of patients with varying OIPN levels. Notably, pathway analysis revealed a significant correlation with lipid metabolism, amino acid metabolism, and energy metabolism. Multivariate statistical analysis and receiver operator characteristic curve evaluation pointed to anhalamine and glycochenodeoxycholic acid as potential biomarkers for OIPN C and A, which suggest that serum metabolomics may serve as a potent tool for exploring the metabolic status of patients suffering from diverse diseases and for discovering novel biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Affiliated Hospital of Jiangnan University, Wuxi, China.
- Department of Pathology, Affiliated Hospital of Jiangnan University, Wuxi, China.
- Medical Oncology Three, Affiliated Hospital of Jiangnan University, Wuxi, China.
ORCID-Profile: Yongjuan Ding, Juan Lv
Förderung
- Lean Medication and Stone Medicine Special Research Fund Supported Project
- Wuxi Municipal Health Commission Youth Project
Zitieren
APA
Hua, Y., Wang, R., Liu, Y., Liu, Q., Qi, X., Ding, Y., & Lv, J. (2024). Metabolomics analysis reveals characteristic metabolites in different levels of oxaliplatin‐induced neurotoxicity. Journal of Separation Science. https://doi.org/10.1002/jssc.202400164
Vancouver
Hua Y, Wang R, Liu Y, Liu Q, Qi X, Ding Y, et al. Metabolomics analysis reveals characteristic metabolites in different levels of oxaliplatin‐induced neurotoxicity. Journal of Separation Science. 2024. doi:10.1002/jssc.202400164
BibTeX
@article{Hua2024,
author = {Hua, Yujiao and Wang, Rong and Liu, Yankui and Liu, Quan and Qi, Xiaowei and Ding, Yongjuan and Lv, Juan},
title = {Metabolomics analysis reveals characteristic metabolites in different levels of oxaliplatin‐induced neurotoxicity},
journal = {Journal of Separation Science},
year = {2024},
doi = {10.1002/jssc.202400164}
}
EUVIMED